PER-031-02已完成未知
MULTICENTRIC, DOUBLE-BLIND, FOUR-PARALLEL GROUP, RANDOMIZED STUDY TO INVESTIGATE THE RESPONSE DOSE OF MICAFUNGIN (FK463) COMPARED WITH FLUCONAZOLE, ADMINISTERED TO HIV-POSITIVE PATIENTS WITH CONFIRMED CANDIDIASIS ESOPHAGITIS
FUJISAWAGMBH (ALEMANIA),0 个研究点目标入组 0 人开始时间: 2002年4月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •The patient must have candidiasis esophagitis, with or without involvement of the oropharyngeal area, without typical signs, documented clinical symptoms and confirmed by endoscopy. A histological / cytological confirmation should be obtained by brushing and esophageal biopsy, the results of which may still be pending at the moment of enrolling the patient.
- •Patient of both sexes older than 18 years.
- •The patient should have veins that are sufficiently accessible to allow medication to be administered.
排除标准
- •Evidence of liver disease.
- •Pregnant or breast-feeding patient.
- •Patient with significant renal disease.
- •Patient with another opportunistic disease.
研究者
相似试验
已完成
Unknown
MULTICENTRIC, DOUBLE-BLIND, FOUR-PARALLEL GROUP, RANDOMIZED STUDY TO INVESTIGATE THE RESPONSE DOSE OF MICAFUNGIN (FK463) COMPARED WITH FLUCONAZOLE, ADMINISTERED TO HIV-POSITIVE PATIENTS WITH CONFIRMED CANDIDIASIS ESOPHAGITISCandidiasisPER-033-02FUJISAWAGMBH (ALEMANIA),
已完成
不适用
Multicentre, parallel group, randomised, double blind study to investigate the efficacy of Montelukast (MK) + Fluticasone (FP) placebo versus Fluticasone + MK-placebo versus MK-placebo + FP-placebo in preschool children with asthma or asthma-like symptoms during a 3 months study periodAsthmaRespiratoryISRCTN38475879Merck Sharp and Dohme BV (Netherlands)150
进行中（未招募）
不适用
A Multi-Center, Double-Blind, Parallel-Group, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Denagliptin in Subjects With Type 2 Diabetes Mellitus”MedDRA version: 8.0Level: LLTClassification code 10045242Type 2 Diabetes MellitusEUCTR2006-002157-79-FIGlaxoSmithKline480
未知
3 期
ubiprostone phase 3 double-blind studychronic idiopathic constipationJPRN-jRCT2080220730Sucampo Pharma, Ltd.116
进行中（未招募）
1 期
Clinical trial in several centers in which patients are administrating randomly in parallel with treatment or placebo (control). Neither the researchers nor the patients know which treatment the patiens are receiving. Present clinical trial evaluates safety and clinical efficacy of intradermal immunotherapy with polymerised Phleum pratense, in patients with allergic rhino-conjunctivitis with or without mild to moderate asthma, sensitized to Phleum pratense pollen.Allergic patients to the pollen of Phleum pratense with allergic rhino-conjunctivitis with or without mild to moderate asthma.MedDRA version: 16.1Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853EUCTR2014-000429-18-ESDIATER, Laboratorio de Diagnóstico y Aplicaciones Terapéuticas, S.A.174